Other
Oxytocin
0
Pipeline Programs↗
15
Active Trials↗
2
Companies Involved↗
Oxytocin is an early-stage landscape with 0 programs across 2 companies. The most active players are Ferring, GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
161
clinical trials
Completed108 · 67%
Unknown status22 · 14%
Recruiting13 · 8%
Withdrawn8 · 5%
Terminated7 · 4%
Not yet recruiting2 · 1%
Other1 · 1%
Clinical Trials
Trial Activity
161 trials
Identifying Oxytocin Deficiency in Adults With Pituitary Disease
Recruiting·—·Phase 1·NCT06460948·32 enrolled
Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM
Recruiting·—·Phase 4·NCT07119398·80 enrolled
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Recruiting·—·Phase 1·NCT04789148·40 enrolled
Oxytocin and Fetal Heart Rate Changes
Recruiting·—·Phase 4·NCT03232918·730 enrolled
Dog Presence and Oxytocin on Trust Towards Therapists
Recruiting·—·Phase 2/3·NCT06248710·176 enrolled
Page 1 of 11
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)